Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
about
The influence of ligand-activated LXR on primary human trophoblasts.Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injuryAnthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXRα pathway in HK-2 cellsEmerging role of liver X receptors in cardiac pathophysiology and heart failure.Liver X receptor α activation with the synthetic ligand T0901317 reduces lung injury and inflammation after hemorrhage and resuscitation via inhibition of the nuclear factor κB pathwayCytokine signaling modulates blood-brain barrier function.Biological roles of liver X receptors in immune cells.Activation of liver X receptors promotes inflammatory cytokine mRNA degradation by upregulation of tristetraprolin.Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.Gene expression profiling of liver X receptor α and Bcl-2-associated X protein in experimental transection spinal cord-injured ratsActivation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats.Mer signaling increases the abundance of the transcription factor LXR to promote the resolution of acute sterile inflammation.Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.
P2860
Q35635035-C38EEC38-9286-439C-B3FE-A40E5AA2D263Q35924690-D2C8B34C-E5BD-4C0E-84FE-46F40C23ACADQ36052340-0E89A57E-151E-43D2-8FEC-0DFCA855F1DDQ36322805-697E2C3F-9B8B-444A-8C89-FD5B2D9BD66AQ37006070-B2CCE236-A191-41B6-A5B2-0C12F03FCF3EQ37612092-FC31D73A-286F-41E4-8D2D-EBC9951C4E0EQ38018555-2511D78A-0F3B-4018-8982-FA8AB77A6F30Q38719602-61A341A7-E375-4862-B566-BA6D6B51BA33Q38929978-A39E9977-4764-4863-ACE8-B2D923904F28Q39442545-27C24340-1E19-42D7-91F3-731F7F6E75AFQ41844560-7A96011B-4D47-4F5B-AD9F-5BE0B04F1490Q42518317-3F83D273-8DAF-4EF0-8D23-A8DFE2361EF3Q49494791-5B42C1A8-A790-4E92-A602-57C4532682F7Q53604237-3394BE01-AF2C-45CF-8CDA-04AD1609A82EQ54286064-B7011EE6-27F3-4793-8382-C2F9EE4B6121
P2860
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@en
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@nl
type
label
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@en
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@nl
prefLabel
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@en
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@nl
P2093
P2860
P50
P356
P1476
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
@en
P2093
Alessandro Cappellani
Concetta Crisafulli
Irene Paterniti
Maria Galuppo
P2860
P304
P356
10.1189/JLB.0609438
P577
2009-12-22T00:00:00Z